Free Trial
LON:N4P

N4 Pharma (N4P) Share Price, News & Analysis

N4 Pharma logo
GBX 0.65 0.00 (0.00%)
(As of 11/21/2024 ET)

About N4 Pharma Stock (LON:N4P)

Key Stats

Today's Range
0.60
0.70
50-Day Range
0.50
0.75
52-Week Range
0.37
1.50
Volume
130,112 shs
Average Volume
1.22 million shs
Market Capitalization
£2.57 million
P/E Ratio
N/A
Dividend Yield
3.12%
Price Target
N/A
Consensus Rating
N/A

Company Overview

N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.

Receive N4P Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for N4 Pharma and its competitors with MarketBeat's FREE daily newsletter.

N4P Stock News Headlines

N4 Pharma PLC (N4P.AQ)
“This Changes Everything” - Trump Hands Millions Massive IRS Gift
Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…
N4 Pharma Plc Share Chat
N4 Pharma Shares Rise on Development of Nuvec Test
See More Headlines

N4P Stock Analysis - Frequently Asked Questions

N4 Pharma's stock was trading at GBX 0.85 at the beginning of the year. Since then, N4P stock has decreased by 23.5% and is now trading at GBX 0.65.
View the best growth stocks for 2024 here
.

N4 Pharma Plc (LON:N4P) released its quarterly earnings data on Thursday, September, 17th. The company reported ($0.48) EPS for the quarter.

Shares of N4P stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that N4 Pharma investors own include 4D pharma (DDDD), Active Energy Group (AEG), B&M European Value Retail (BME), BP (BP), Coats Group (COA), EQTEC (EQT) and genedrive (GDR).

Company Calendar

Last Earnings
9/17/2020
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Net Income
£-1,080,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£23,524.00
Cash Flow
GBX 0.29 per share

Miscellaneous

Free Float
N/A
Market Cap
£2.57 million
Optionable
Not Optionable
Beta
-0.37
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (LON:N4P) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners